Posted in | News | Nanomedicine

RainDance Technologies Announces Commercial Sale of RDT 1000 and Sequence Enrichment Solution to Expression Analysis

RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced the commercial sale of an RDT 1000 and Sequence Enrichment Solution to Expression Analysis, Inc., a leading provider of genomic services for clinical trials and research.

The RainDance solution will enable Expression Analysis to expand its service offerings to provide genomic researchers quality and efficient targeted sequencing on large sample numbers.

“As the market leader in genomic outsourcing for gene expression, genotyping, and resequencing analysis, we enable our service offerings using best-in-class systems. RainDance Technologies is clearly in this class, and we are proud to incorporate their technology to further expand our suite of services and look forward to offering expanded DNA sequencing applications,” said Steve McPhail, President and Chief Executive Officer of Expression Analysis.

The announcement marks the first sale of the RainDance solution to a service provider. The solution consists of an RDT 1000, consumables kits, custom PCR primer libraries, and expert training.

“As a leading genomic service provider, Expression Analysis’ decision to embrace our platform accelerates the ability of researchers to access our sequence enrichment technology,” said Christopher McNary, President and Chief Executive Officer of RainDance Technologies.

The RDT 1000 and Sequence Enrichment Solution utilize RainDance’s breakthrough RainStorm™ microdroplet-based technology platform. The simplicity and speed of the technology are designed to maximize the efficiency of next-generation DNA sequencing workflows. The RDT 1000 generates picoliter-volume PCR reactions at the rate of 10 million discrete reactions per hour. The high-speed sample processing is further enhanced by the fact that the Sequence Enrichment Solution utilizes a library of PCR primers in droplets, enabling the amplification of hundreds to thousands of genomic loci in a single tube. The RainStorm format avoids the limitations of traditional multiplex hybridization and amplification technologies. RainDance’s solution minimizes process-induced bias or error and requires only a few micrograms of genomic DNA.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    RainDance Technologies, Inc.. (2019, February 14). RainDance Technologies Announces Commercial Sale of RDT 1000 and Sequence Enrichment Solution to Expression Analysis. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=10969.

  • MLA

    RainDance Technologies, Inc.. "RainDance Technologies Announces Commercial Sale of RDT 1000 and Sequence Enrichment Solution to Expression Analysis". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=10969>.

  • Chicago

    RainDance Technologies, Inc.. "RainDance Technologies Announces Commercial Sale of RDT 1000 and Sequence Enrichment Solution to Expression Analysis". AZoNano. https://www.azonano.com/news.aspx?newsID=10969. (accessed April 19, 2024).

  • Harvard

    RainDance Technologies, Inc.. 2019. RainDance Technologies Announces Commercial Sale of RDT 1000 and Sequence Enrichment Solution to Expression Analysis. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=10969.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.